Home
Search
About
Contact
Briefly Legal: Was Kernicterus the Cause of the Adverse Outcome?
February 28, 2023
/
18
,
Diagnosis
,
Medical Practices
,
Medico-legal
,
Neurodevelopment
,
Treatment
Maureen Sims, MD, Barry Schifrin, MD
nt-23-02-049-053
Download
←
Previous:
Fellow’s Column: Diagnostic and Treatment Challenges in Multisystem Inflammatory Syndrome in Neonates (MIS-N): A Success Story with Anakinra
Next:
Gravens By Design: A Preview of Evidence-Based Programs for the Developmental and Family-Centered Care Track at the 36th Gravens Meeting
→
